Global mRNA Vaccines & Therapeutics Market Research Report 2023
- Report Code : INT2493283
- Published On: May, 2021
- Category : Healthcare & Pharma
- Pages : 180
-
Research Predicts that mRNA Vaccines & Therapeutics Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global mRNA Vaccines & Therapeutics Market Overview:
Global mRNA Vaccines & Therapeutics Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of mRNA Vaccines & Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on mRNA Vaccines & Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the mRNA Vaccines & Therapeutics market in 2020.
Global mRNA Vaccines & Therapeutics Market Segmentation
By Type, mRNA Vaccines & Therapeutics market has been segmented into:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Application, mRNA Vaccines & Therapeutics market has been segmented into:
Hospital
Clinic
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in mRNA Vaccines & Therapeutics market are:
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics
-
With tables and figures helping analyze worldwide Global mRNA Vaccines & Therapeutics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1. Market Overview of mRNA Vaccines & Therapeutics1.1 mRNA Vaccines & Therapeutics Market Overview
1.1.1 mRNA Vaccines & Therapeutics Product Scope
1.1.2 Market Status and Outlook1.2 mRNA Vaccines & Therapeutics Market Size by Regions: 2015 VS 2021 VS 2026
1.3 mRNA Vaccines & Therapeutics Historic Market Size by Regions (2015-2020)
1.4 mRNA Vaccines & Therapeutics Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact mRNA Vaccines & Therapeutics Sales Market by Type (2015-2026)2.1 Global mRNA Vaccines & Therapeutics Historic Market Size by Type (2015-2020)
2.2 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Type (2021-2026)
2.3 Standardization Of Cancer Treatment MRNA Vaccine
2.4 Individualized Cancer Treatment MRNA Vaccine
2.5 Infectious Disease Treatment MRNA Vaccine
2.6 Infection Prevention MRNA Vaccine
3. Covid-19 Impact mRNA Vaccines & Therapeutics Sales Market by Application (2015-2026)3.1 Global mRNA Vaccines & Therapeutics Historic Market Size by Application (2015-2020)
3.2 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Application (2021-2026)
3.3 Hospital
3.4 Clinic
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers4.1 Global mRNA Vaccines & Therapeutics Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2015-2020)
4.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in mRNA Vaccines & Therapeutics Business5.1 Argos Therapeutics
5.1.1 Argos Therapeutics Company Profile
5.1.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Specification
5.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.2 AstraZeneca
5.2.1 AstraZeneca Company Profile
5.2.2 AstraZeneca mRNA Vaccines & Therapeutics Product Specification
5.2.3 AstraZeneca mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.3 Bayer
5.3.1 Bayer Company Profile
5.3.2 Bayer mRNA Vaccines & Therapeutics Product Specification
5.3.3 Bayer mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.4 BioNTech
5.4.1 BioNTech Company Profile
5.4.2 BioNTech mRNA Vaccines & Therapeutics Product Specification
5.4.3 BioNTech mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Company Profile
5.5.2 Boehringer Ingelheim mRNA Vaccines & Therapeutics Product Specification
5.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.6 CRISPR Therapeutics
5.6.1 CRISPR Therapeutics Company Profile
5.6.2 CRISPR Therapeutics mRNA Vaccines & Therapeutics Product Specification
5.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 CureVac
5.7.1 CureVac Company Profile
5.7.2 CureVac mRNA Vaccines & Therapeutics Product Specification
5.7.3 CureVac mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 eTheRNA immunotherapies
5.8.1 eTheRNA immunotherapies Company Profile
5.8.2 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Product Specification
5.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Ethris
5.9.1 Ethris Company Profile
5.9.2 Ethris mRNA Vaccines & Therapeutics Product Specification
5.9.3 Ethris mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.10 GlaxoSmithKline Vaccines
5.10.1 GlaxoSmithKline Vaccines Company Profile
5.10.2 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Product Specification
5.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 In-Cell-Art
5.11.1 In-Cell-Art Company Profile
5.11.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Specification
5.11.3 In-Cell-Art mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Intellia Therapeutics
5.12.1 Intellia Therapeutics Company Profile
5.12.2 Intellia Therapeutics mRNA Vaccines & Therapeutics Product Specification
5.12.3 Intellia Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Janssen
5.13.1 Janssen Company Profile
5.13.2 Janssen mRNA Vaccines & Therapeutics Product Specification
5.13.3 Janssen mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Kernal Biologics
5.14.1 Kernal Biologics Company Profile
5.14.2 Kernal Biologics mRNA Vaccines & Therapeutics Product Specification
5.14.3 Kernal Biologics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 MaxCyte
5.15.1 MaxCyte Company Profile
5.15.2 MaxCyte mRNA Vaccines & Therapeutics Product Specification
5.15.3 MaxCyte mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Moderna Therapeutics
5.16.1 Moderna Therapeutics Company Profile
5.16.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Specification
5.16.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Novartis
5.17.1 Novartis Company Profile
5.17.2 Novartis mRNA Vaccines & Therapeutics Product Specification
5.17.3 Novartis mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 PhaseRx
5.18.1 PhaseRx Company Profile
5.18.2 PhaseRx mRNA Vaccines & Therapeutics Product Specification
5.18.3 PhaseRx mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Precision NanoSystems
5.19.1 Precision NanoSystems Company Profile
5.19.2 Precision NanoSystems mRNA Vaccines & Therapeutics Product Specification
5.19.3 Precision NanoSystems mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.20 RaNa Therapeutics
5.20.1 RaNa Therapeutics Company Profile
5.20.2 RaNa Therapeutics mRNA Vaccines & Therapeutics Product Specification
5.20.3 RaNa Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America6.1 North America mRNA Vaccines & Therapeutics Market Size (2015-2026)
6.2 North America mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
6.3 North America mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
6.4 North America mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
7. East Asia7.1 East Asia mRNA Vaccines & Therapeutics Market Size (2015-2026)
7.2 East Asia mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
7.3 East Asia mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
7.4 East Asia mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
8. Europe8.1 Europe mRNA Vaccines & Therapeutics Market Size (2015-2026)
8.2 Europe mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
8.3 Europe mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
8.4 Europe mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
9. South Asia9.1 South Asia mRNA Vaccines & Therapeutics Market Size (2015-2026)
9.2 South Asia mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
9.3 South Asia mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
9.4 South Asia mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
10. Southeast Asia10.1 Southeast Asia mRNA Vaccines & Therapeutics Market Size (2015-2026)
10.2 Southeast Asia mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
10.3 Southeast Asia mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
11. Middle East11.1 Middle East mRNA Vaccines & Therapeutics Market Size (2015-2026)
11.2 Middle East mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
11.3 Middle East mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
11.4 Middle East mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
12. Africa12.1 Africa mRNA Vaccines & Therapeutics Market Size (2015-2026)
12.2 Africa mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
12.3 Africa mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
12.4 Africa mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
13. Oceania13.1 Oceania mRNA Vaccines & Therapeutics Market Size (2015-2026)
13.2 Oceania mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
13.3 Oceania mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
13.4 Oceania mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
14. South America14.1 South America mRNA Vaccines & Therapeutics Market Size (2015-2026)
14.2 South America mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
14.3 South America mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
14.4 South America mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
15. Rest of the World15.1 Rest of the World mRNA Vaccines & Therapeutics Market Size (2015-2026)
15.2 Rest of the World mRNA Vaccines & Therapeutics Key Players in North America (2015-2020)
15.3 Rest of the World mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)
15.4 Rest of the World mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)
16 mRNA Vaccines & Therapeutics Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
-
The Global mRNA Vaccines & Therapeutics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The flow of investment into the Global mRNA Vaccines & Therapeutics Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.
Depending upon the type of applications, the Global mRNA Vaccines & Therapeutics Market has been segmented into
The Global mRNA Vaccines & Therapeutics Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
The Global mRNA Vaccines & Therapeutics Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
The Global mRNA Vaccines & Therapeutics study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
